SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson ...
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...
Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
Windsor resident beating the odds following devastating diagnosis and treatment for usually deadly form of pancreatic cancer.